Ionis Pharmaceuticals, Inc. (BMV:IONS)
Mexico
· Delayed Price · Currency is MXN 1,150.00
+50.00 (4.55%)
At close: Sep 24, 2025
Ionis Pharmaceuticals Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -381.39 | -453.9 | -366.29 | -269.72 | -28.6 | Upgrade
|
| Depreciation & Amortization | 22.69 | 21.99 | 22.5 | 22.11 | 19.56 | Upgrade
|
| Other Amortization | 6.91 | 6.69 | 6.33 | 5.37 | 4.96 | Upgrade
|
| Loss (Gain) From Sale of Assets | -3.01 | 10.44 | 18.47 | -147.57 | 2.71 | Upgrade
|
| Loss (Gain) From Sale of Investments | -33.02 | -34.84 | -27.3 | 7.61 | 16.68 | Upgrade
|
| Stock-Based Compensation | 133.87 | 130.2 | 105.81 | 100.26 | 120.68 | Upgrade
|
| Other Operating Activities | 36.56 | 27.87 | 10.22 | - | 8.63 | Upgrade
|
| Change in Accounts Receivable | 26.13 | 5.59 | -72.06 | 36.36 | 14.31 | Upgrade
|
| Change in Inventory | -13.67 | -5.07 | -2.47 | 5.33 | -2.84 | Upgrade
|
| Change in Accounts Payable | -15.36 | 15.99 | 8.12 | 1.09 | -6 | Upgrade
|
| Change in Unearned Revenue | -69.73 | -156.82 | 13.97 | -71.25 | -82.83 | Upgrade
|
| Change in Income Taxes | 2.68 | -2.12 | -4.1 | 6.21 | -0.28 | Upgrade
|
| Change in Other Net Operating Assets | 18.74 | -66.96 | -20.72 | 29.83 | -36.18 | Upgrade
|
| Operating Cash Flow | -268.58 | -500.95 | -307.51 | -274.37 | 30.8 | Upgrade
|
| Operating Cash Flow Growth | - | - | - | - | -14.19% | Upgrade
|
| Capital Expenditures | -51.44 | -45.28 | -23.81 | -15.72 | -11.96 | Upgrade
|
| Sale (Purchase) of Intangibles | -5.64 | -5.06 | -4.18 | -4.38 | -5.95 | Upgrade
|
| Sale (Purchase) of Real Estate | - | - | - | 254.08 | - | Upgrade
|
| Investment in Securities | -220.69 | -83.69 | -186.14 | -496.62 | 212.81 | Upgrade
|
| Investing Cash Flow | -277.78 | -134.03 | -214.13 | -262.64 | 194.91 | Upgrade
|
| Long-Term Debt Issued | 770 | - | 575 | - | 632.5 | Upgrade
|
| Long-Term Debt Repaid | -267.82 | -44.67 | -488.1 | -50.69 | -318.93 | Upgrade
|
| Net Debt Issued (Repaid) | 502.19 | -44.67 | 86.9 | -50.69 | 313.57 | Upgrade
|
| Issuance of Common Stock | 192.6 | 522.73 | 49.44 | 6.37 | 11.57 | Upgrade
|
| Repurchase of Common Stock | - | - | - | -10.95 | -16.73 | Upgrade
|
| Other Financing Activities | -18.95 | - | 507.74 | -0.03 | -62.48 | Upgrade
|
| Financing Cash Flow | 675.84 | 478.06 | 644.08 | -55.3 | 245.93 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0.7 | -0.27 | 0.35 | -0.42 | -0.11 | Upgrade
|
| Net Cash Flow | 130.18 | -157.19 | 122.79 | -592.72 | 471.53 | Upgrade
|
| Free Cash Flow | -320.03 | -546.23 | -331.32 | -290.09 | 18.84 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | 2340.93% | Upgrade
|
| Free Cash Flow Margin | -33.91% | -77.46% | -42.06% | -49.39% | 2.33% | Upgrade
|
| Free Cash Flow Per Share | -2.00 | -3.65 | -2.31 | -2.04 | 0.13 | Upgrade
|
| Cash Interest Paid | 10.78 | 10.87 | 6.51 | 2.9 | 4.78 | Upgrade
|
| Cash Income Tax Paid | -0.64 | -5.62 | 48.33 | 5.01 | 0.04 | Upgrade
|
| Levered Free Cash Flow | -154.72 | -352.83 | -173.51 | -80.22 | 76.54 | Upgrade
|
| Unlevered Free Cash Flow | -105.04 | -302.98 | -128.93 | -80.51 | 77.42 | Upgrade
|
| Change in Working Capital | -51.22 | -209.39 | -77.26 | 7.57 | -113.82 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.